The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a cause for the reported thrombosis/thrombus cannot be determined; however thrombosis is listed in the instructions for use (ifu) as a known possible complication associated with mitraclip procedures.The medication required and unexpected medical intervention were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|
This is filed to report a thrombus.It was reported that on (b)(6) 2022 three mitraclips were implanted during a procedure to treat degenerative mitral regurgitation (mr) grade 4.The procedure reduced the mr to grade 1.Due to decompensation, the patient was hospitalized.The mr had returned to grade 4.All three clips were observed to be stable on the leaflets.Per the physician the increase in mr was due to progression of disease.On (b)(6) 2022 another clip was to be implanted to reduce the mr.When the steerable guide catheter (sgc) was in the right atrium, a thrombus was observed.Physician applied additional heparin and aspirated the thrombus successfully via the sgc.Sgc was removed out of the patient and flushed again.A fourth clip was then successfully implanted reducing the mr to grade 2.There was no clinically significant delay.No additional information was provided.
|